Hovione
Matteo Seregni is a seasoned professional in business development and sales within the pharmaceutical industry, currently serving as the Regional Sales Director for North America and Israel at Hovione since September 2021. With a strong background in contract negotiation and marketing, Matteo supports Hovione's off-patent API and bioexcipient portfolio. Previous positions include Business Development Director at Ardena and Crystallics, where Matteo demonstrated a proactive approach and commitment to high professional standards. Additional experience encompasses managing a business unit at Akka Technologies, co-founding Unglitch, and participating in various educational programs, including an Executive MBA from Quantic School of Business and Technology. Matteo's educational background also includes studies at renowned institutions such as Politecnico di Milano and IE Business School.
This person is not in any offices
Hovione
2 followers
Hovione is an international company with over 60 years of experience in pharmaceutical development and manufacturing operations. As a Contract Development and Manufacturing Organization (CDMO) with a fully integrated offering of services for drug substances, drug product intermediates and drug products. The company has four FDA inspected sites in the USA, Portugal, Ireland and China and development laboratories in Lisbon, Portugal and New Jersey, USA. Hovione provides pharmaceutical customers services for the development and compliant manufacture of innovative drugs, including highly potent compounds, and customized product solutions across the entire drug life cycle. In the inhalation area, Hovione offers a complete range of services, from API, formulation development and devices. Hovione´s culture is based on innovation, quality and dependability. Hovione was the first Chemical/ Pharmaceutical Company to become a Certified B Corp, is a member of Rx-360, EFCG and participates actively in industry quality improvement initiatives to lead new global industry standards.